baber/WOPTO huggingface dataset:
Patent JP-S6024579-B2 (JP)
IPC: H01L29/06
Filed: 1975-08-28
Abstract: Described is a molecular beam technique for fabricating semiconductor devices from Group III(a)-V(a) compounds. To form planar isolated devices, an amorphous insulative layer is formed on selected portions of a monocrystalline substrate of the Group III(a)-V(a) material which is at least semi-insulating. The amorphous layer may be formed by deposition of an oxide (e.g., SiO2), anodization of an oxide (e.g., native oxides) or by conversion of a surface layer of the substrate (e.g., by grit blasting). When a molecular beam containing Group III(a) and Group V(a) elements is directed at the surface, which is preheated to a temperature in the range of 450 DEG  to 675 DEG  C, monocrystalline Group III(a)-V(a) material grows on the exposed substrate whereas polycrystalline Group III(a)-V(a) material is simultaneously formed on the amorphous layer. The polycrystalline and monocrystalline surfaces are substantially coplanar. The polycrystalline material has a resistivity high enough to provide electrical isolation between active devices formed in the monocrystalline material. Examples of such active devices, which are also described, include beam-leaded Schottky barrier mixer diodes which have reduced parasitic capacitance and sealed-junction Schottky barrier IMPATT diodes. To form devices in which isolation is not required, the same procedure is followed except that neither the amorphous layer nor the substrate need be made of high resistivity material.
Patent JP-2721507-B2 (JP)
IPC: A61K31/135
Filed: 1988-05-02
Granted: 1998-03-04
Abstract: Fluoxetine has been found to control diabetes in mammals.
Patent JP-H0729923-B2 (JP)
IPC: A61K31/435
Filed: 1986-05-21
Abstract: Compsn. comprises castanozpermine (ie. IS, 6S, 7R. 8R, (aR - 1, 6, 7, 8-tetrc enydroxyindolizidine) of formula (I).
Patent JP-2980641-B2 (JP)
IPC: A61C13/23
Filed: 1990-05-02
Granted: 1999-11-22
Abstract: Disclosed are stabilizer compositions comprising specific mixed partial salts of a lower alkyl vinyl ether-maleic acid copolymer wherein said partial salts contain as the cationic salt function:  (a) from about 10% to about 65% zinc or strontium cations; and  (b) from about 10% to about 75% calcium cations of the total initial carboxyl groups reacted. Also disclosed are denture stabilizing compositions comprising these mixed partial salts, as well as denture stabilizing compositions comprising a safe and adhesively effective amount of two or more denture adhesive components wherein one of said denture adhesive components is the mixed partial salt(s) of the present invention.
Patent JP-H0123401-B2 (JP)
IPC: C01B15/029
Filed: 1984-06-22
Abstract: A process for making hydrogen peroxide from hydrogen and oxygen at superatmospheric pressures employing, as catalyst, Pd on adsorbent carbon in a ratio of more than about one-half percent Pd based on the weight of Pd plus C, the reaction being run in an aqueous medium comprising substantially no organic component.
Patent JP-2618851-B2 (JP)
IPC: B60J1/17
Filed: 1984-06-22
Granted: 1997-06-11
Abstract: 1. A window pane, especially a pane for an automobile vehicle, on the periphery of which a metal surround is engaged by clamping, characterized in that the pane (1) is provided, on a peripheral zone in contact with the surround (9, 12, 17) on at least on of its surfaces with a coating (4, 22) based on a highly elastic polymer which adheres strongly to the glass of the plane.
Patent JP-4194685-B2 (JP)
IPC: A61F13/00
Filed: 1998-05-18
Granted: 2008-12-10
Abstract: A compression bandage system is disclosed comprising an inner skin facing layer and an elastic outer layer. The inner layer comprises a first ply of foam and a second ply of an absorbent nonwoven web. Both the inner and outer layers are sufficiently elongated so as to be capable of being wound about a patient's limb. Preferably, the foam comprises an ester based polyurethane. The nonwoven web preferably comprises carded fibers, especially cotton fibers, which are needle punched to the foam at less than 500 needles per inch, more preferably at less than 200 needles per inch, and most preferably at less than 100 needles per inch.
Patent JP-H0117880-B2 (JP)
IPC: B41M3/00
Filed: 1979-11-30
Abstract: A process for the reproduction of oil painting and the like, having a relief surface, using a relief mold taken from the original and a thermoplastic foil, imprinted with a color picture corresponding to the original, the foil being molded while being heated and which includes placing the foil upon the relief mold in a fitting alignment and heating the foil essentially homogeneously to its liquefying temperature across its entire surface.
Patent JP-H0564200-B2 (JP)
Inventor: IBAN HAABOTSU
IPC: C11D3/43
Filed: 1984-08-10
Abstract: Stain removal composition comprise mixtures of grease-cutting solvents and polyamines. The compositions are particularly useful for removing stains comprising a mixture of grease and particulate matter from fabrics. Liquid detergents containing said solvents and polyamines in the form of stable oil-in-water microemulsions are disclosed.
Patent JP-3250180-B2 (JP)
IPC: B29C45/76
Filed: 1998-06-17
Granted: 2002-01-28
Abstract: A motor-driven injection molding machine comprises an injection device which includes a heating cylinder for heating resin powder therein to melt the resin powder into molten resin and a screw disposed in the heading cylinder for feeding the molten resin in the heating cylinder forward to meter the molten resin. A controller (26) positions, in response to a position detected signal (Sfb) detected by a position detector (27), the screw at a metering position using an injection servomotor (11) on and immediately after completion of the plasticization and metering process. In addition, the controller (26) rotates, in response to a pressure detected signal (Pfb) detected by a load cell (18), the screw in the opposite direction using a screw-rotation servomotor (24) on and immediately after the completion of said plasticization and metering process to carry out depressurization of the molten resin in the heating cylinder that is metered ahead of the screw. <IMAGE>
Patent JP-3238801-B2 (JP)
IPC: C07D401/12
Filed: 1993-06-23
Granted: 2001-12-17
Abstract: The subject of the invention is pyrazole derivatives of formula I:   <IMAGE>  in which   - g2, g3, g4, g5, g6 and w2, w3, w4, w5 and w6 are identical or different and independently represent hydrogen, a chlorine or bromine atom, a (C1-C3)alkyl, a (C1-C3)alkoxy, a trifluoromethyl or a nitro group and g4 optionally represents a phenyl group;   - R4 represents hydrogen or a (C1-C3)alkyl; - X represents either a direct bond or a group -(CH2)x-N(R3)- in which R3 represents hydrogen or a (C1-C3)alkyl and x represents zero or one;   - R represents   . a group -NR1R2, in which R1 and R2 independently represent a (C1-C6)alkyl group; an optionally substituted, nonaromatic (C3-C15)carbocyclic radical; an amino(C1-C4)alkyl group in which the amino is optionally disubstituted by a (C1-C3)alkyl; a cycloalkyl(C1-C3)alkyl in which the cycloalkyl is (C3-C12); a phenyl which is unsubstituted or substituted one or more times by a halogen, by a (C1-C5)alkyl or by a (C1-C5)alkoxy; a phenyl(C1-C3)alkyl; a diphenyl(C1-C3)alkyl; a naphthyl; an anthryl; a saturated, 5- to 8-membered heterocyclic radical which is unsubstituted or substituted by a (C1-C3)alkyl, hydroxyl or benzyl; a 1-adamantylmethyl; an aromatic heterocycle which is unsubstituted or substituted one or more times by a halogen, a (C1-C5)alkyl or a (C1-C5)alkoxy; a (C1-C3)alkyl which is substituted by an aromatic heterocycle which is unsubstituted or substituted one or more times by a halogen, a (C1-C5)alkyl or a (C1-C5)alkoxy; or else R1 is hydrogen and R2 is as defined above; or yet again R1 and R2 constitute, with the nitrogen atom to which they are bonded, a saturated, 5- to 8-membered heterocyclic radical, the said heterocyclic radical being other than morpholinyl when w2, w3, w4, w5, w6, g2, g3, g4, g5 and g6 are all hydrogen;   . a group R2 as defined above when X represents -(CH2)xN(R3)-; . a group R5 when X represents a direct bond, R5 being represented by a (C1-C3)alkyl; a (C3-C12)cycloalkyl which is unsubstituted or substituted by a (C1-C5)alkyl; a phenyl(C1-C3)alkyl which is unsubstituted or substituted by a halogen or by a (C1-C5)alkyl; a cycloalkyl(C1-C3)alkyl in which the cycloalkyl is C3-C12 and is unsubstituted or substituted by a (C1-C5)alkyl; or a 2-norbornylmethyl;    or one of their optional salts. Application: therapeutic treatment of pathological conditions where cannabis is involved.
Patent JP-H0260117-B2 (JP)
IPC: H04N3/10
Filed: 1983-09-26
Abstract: Flat picture reproduction device for displaying color pictures based upon three basic colors, containing a vacuum-tight envelope with an electrode matrix formed of row conductors and column conductors arranged in front of the row conductors. It has cutouts at the intersections of the row and column conductors and divides the interior of the envelope into a rear and a front chamber. A planar electron source is located in the rear chamber, elongated deflection electrodes located in the front chamber, between adjacent column conductors. The odd-numbered deflection electrodes are connected to a first voltage source, and the even-numbered ones to a second voltage source. Strip-shaped layers of luminescent phosphor is applied to the front side of the envelope wall adjacent one another in a periodic color sequence parallel to the column conductors. An addressing circuit is provided which has means for scanning the row conductors sequentially, and means for providing the column conductors, during a row scanning time interval and in the sequence of colors, with white dot information potentials in a manner that electrons supplied by the electron source can pass selectively through the cutouts formed in the electrode matrix, and means for applying different potentials to the deflection electrodes so that the electrons entering the front chamber are directed to the respective luminescent strips having the correct color.
Patent JP-H0730022-B2 (JP)
Inventor: ACKERMANN JEAN DR
IPC: C07D413/12
Filed: 1991-07-01
Abstract: The novel guanidines of the formula 
<IMAGE>
 in which, L, M, R, T and X have the meaning given in the description, and hydrates or solvates thereof, inhibit thrombin-induced platelet aggregation and fibrinogen clotting in the plasma, are prepared by amidination, or by amide formation or esterification, depending on whether L is NH or O.
Patent JP-H072736-B2 (JP)
IPC: A01N43/40
Filed: 1985-08-27
Abstract: The present invention provides novel nitromethylene derivatives of the formula (I)   <IMAGE>   wherein R represents a hydrogen atom or an alkyl group, X represents a haloalkyl, haloalkoxy, haloalkylthio, haloalkylsulfinyl, haloalkylsulfonyl, nitro, cyano, thiocyanato, haloalkenyl, haloalkynyl, hydroxyl, alkoxycarbonyl, amino, acyl, dialkylamino, aclamino or alkoxy group, l represents 1, 2 or 3 provided that when l is 1, X does not represent an alkoxy group and when l is 2 or 3, not all substituents X represent an alkoxy group, m represent 2, 3 or 4, and n represents 0 or 1, and the use of the new compounds as insecticides.
Patent JP-3659989-B2 (JP)
IPC: A61P31/12
Filed: 1994-08-23
Granted: 2005-06-15
Abstract: A stereoselective process for preparing a  beta -anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonate intermediates by contacting an  alpha -anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-fluoroalkyl and fluoroaryl sulfonate with a conjugate anion of a sulfonic acid containing the desired alkyl or aryl sulfonate.
Patent JP-3612178-B2 (JP)
IPC: A61K31/5578
Filed: 1997-08-04
Granted: 2005-01-19
Abstract: The present invention relates to the use of certain prostaglandin derivatives for the manufacture of a medicament for the treatment of glaucoma and ocular hypertension. It also relates to a respective opthalmological composition.
Patent JP-H0562276-B2 (JP)
Inventor: OTOMAA SHEEN
IPC: F16K37/00
Filed: 1985-10-11
Abstract: 1. Control valve, in particular throttle valve, with a valve stem (11) supporting a valve member (15), which stem (11) is arranged to move longitudinally in a valve sleeve (6) by means of a screw-coupling (9, 10), and with a rotary knob (21, 25) connected to the valve stem in a non-rotary manner by an entrainment member (20), which rotary knob is held in its axial position by a retaining member (26, 28) passing radially therethrough and engaging in an annular groove (27) in the valve sleeve and whereof the base (22) serves as a stop for the entrainment member, characterised in that : the valve stem comprises a locking groove (12), in which a locking member (17) located in the valve sleeve engages, the locking groove (12) and the locking member (17) are constructed so that the valve member (15) can occupy any position between its closed position and its widest open position, the valve member is prevented from exceeding its widest open position by the side wall of the locking groove (12) adjacent to the valve member (15), which side wall is provided for abutment with the locking member (17), and provided between the valve member (15) and the external thread (10) of the valve stem (11) is a predetermined breaking point, preferably in the region of the locking groove (12), the locking member (17) engaging on the valve stem (11) between the predetermined breaking point and the valve member (15).
Patent JP-H0694599-B2 (JP)
IPC: C25D5/02
Filed: 1984-11-07
Abstract: In the apparatus, loose-piece terminals (15) are fed (114) to a rotating mandrel (3), and are releasably secured by retaining means (132). The mandrel (3) has a plurality of anode extentions (29) and associated nozzles (26) therein. Said anode extensions are mounted for reciprocation into receptacle portions (118) of secured terminals (15). A conduit (36) supplies pressurised plating fluid through the nozzles (26), to the anode extensions (29) and into the receptacle portions of the terminals to enable selective plating of internal surface portions. Retaining means (132) is an elongate resiliently mounted member surrounding a portion (126) of the mandrel (3) to hold terminals (15) against the mandrel (3) during the plating process. After plating the anode extension (29) are retracted from the terminals (15), said terminals are thereafter released when they pass the end of retaining means (132). A terminal so selectively plated has an internal plating of at least 3.81 x 10<-><7> meters with edge margins of tapered thickness covering at least portions of sheared edges of the terminal.
Patent JP-H054069-B2 (JP)
IPC: C12P13/00
Filed: 1984-11-28
Abstract: Indanyl compounds of the formula   <IMAGE>   wherein R1 and R2 are hydrogen, fluorine or chlorine, is useful in the treatment of inflammatory and allergic diseases are prepared by fermenting indanyl compounds of the formula   <IMAGE>  with a culture of Aspergillus niger or Polyporus tulipiferus.
Patent JP-3113093-B2 (JP)
IPC: B60R21/16
Filed: 1992-08-31
Granted: 2000-11-27
Abstract: PURPOSE:To determine the current feeding time to a squib in consideration a chattering of a mechanical switch. CONSTITUTION:When a CPU 9 recognizes a collision depending on the input of a G sensor 10, FETs 3 and 4 are turned ON. When a mechanical switch 5 is turned ON, and the FETs 3 and 4 are operated ON, a current is fed to a squib 2 so as to operate an air bag. When the current was fed to the squib 2 in a scheduled time, the FETs are turned OFF by deciding that a sufficient energy has been given to ignite the squib 2. The measuring value of the time of feeding the current to the squib 2, that is the ON time, is cleared by the interruption by an interrupt circuit 11. This interruption is generated when the mechanical switch 5 is turned ON. As a result, the FETs can be turned OFF depending on the continued current feeding time, except for a chattering time of the mechanical switch.
Patent JP-3773970-B2 (JP)
IPC: C12N15/09
Filed: 1995-09-29
Granted: 2006-05-10
Abstract: The plastics holder assembly includes a tray having a number of holes for receiving the tubes and having opposite vertical end walls, each of which have two spaced vertically extending slots and a horizontally extending recess between the slots. A retainer is releasably nestable in the tray having a corresponding number of holes and having opposite vertical end walls corresponding to the end walls of the tray. A U-shaped handle extends horizontally outwardly from each of the opposite retainer end walls, each handle having two legs which slide into the tray slots respectively when the retainer is nested in the tray. There is a tab projecting horizontally outwardly from each of the retainer end walls between each of the two legs which snap into the tray end wall recesses respectively when the retainer is nested in the tray. The retainer has an elongated slot parallel and directly adjacent each of the end walls, whereby inwardly directed finger pressure on the U-shaped handles inwardly flex the opposite ends of the retainer to release the tabs from the tray recesses respectively to facilitate removal of the retainer from the tray.
Patent JP-H0824692-B2 (JP)
IPC: A61F13/534
Filed: 1986-11-04
Abstract: The present invention provides a disposable absorbent article such as an incontinent pad that is both comfortable and suitable for absorbing and containing large volumes of body liquids rapidly without leakage, especially a subsequent gush of liquid. Such an absorbent article comprises a liquid pervious topsheet, a liquid impervious backsheet, a layered expandable absorbent core positioned between the topsheet and the backsheet, at least two resilient shaping members, an acquisition channel, a liquid acquisition zone and at least two liquid impervious shelves. The present invention also relates to an absorbent article provided with an expandable overwrap having an expansion means for allowing the overwrap to expand when the absorbent core swells when wetted. The liquid impervious shelves comprise a multiplicity of shelf layers formed from a portion of the backsheet being folded. The liquid impervious shelves channel the flow of liquids toward the lower layers of the absorbent core and encourage use of the bottom and sides of the layers, thereby providing more efficient use of hydrogel materials. An anti-bunching bead may be placed on each liquid impervious shelf between the shelf layers to provide stability to the absorbent article.
Patent JP-H07103120-B2 (JP)
IPC: C07D471/04
Filed: 1987-10-20
Abstract: 2-Amino-4-hydroxy-6-[2-(4-carboxyphenyl)alk-1-en-1-yl)pyrido[2,3-d]pyr imidin e s and 2-amino-4-hydroxy-6[2-(4-carboxyphenyl)alk-1-yn-1-yl]pyrido[2,3-d]pyri midines are prepared through the reaction of a haloaromatic compound and an unsaturated compound in the presence of a palladium catalyst. The products are chemical intermediates for the preparation of antineoplastic agents. A typical embodiment is the reaction of a protected 2-amino-4-hydroxy-6-ethynylpyrido[2,3-d]pyrimidine and an ester of 4-iodobenzoic acid.
Patent JP-3188292-B2 (JP)
IPC: A61K47/48
Filed: 1991-07-22
Granted: 2001-07-16
Abstract: Pharmaceutical compositions for continuous release of a physiologically active substance in which the physiologically active substance comprises a polypeptide covalently conjugated to a water soluble polymer show particularly desirable release characteristics. Polypeptides for use in the pharmaceutical compositions include G-CSF and solution stable derivatives thereof, human calcitonin and interleukin-2. The material of the composition may be a polylactide or biodegradable hydrogel derived from an amphipathic block copolymer. The compositions enable a therapeutically effective polypeptide to be continuously released over a prolonged period of time following a single administration of the pharmaceutical composition to a patient.   <IMAGE>
Patent JP-H0472798-B2 (JP)
IPC: C30B25/10
Filed: 1987-12-22
Abstract: A mixture of hydrogen and methane gases is subjected to combined thermal heating and microwave radiation to form a gas plasma which is caused to condense on a substrate as diamond form of carbon.
Patent JP-2558131-B2 (JP)
IPC: A61K31/085
Filed: 1987-12-25
Granted: 1996-11-27
Abstract: New antineoplastic compounds have been isolated, structurally elucidated and synthesized having a general structural formula of: <CHEM>  wherein:  R1 is OH or OCH3;  R2 is H or OCH3; or R1R2 is -OCH2O-;  R3 is H or OH; and R4 is OH or OCH3 and wherein the configuration of the double bond in compounds of formula I is cis. These substances have been denominated "combretastatin A-1, -A-2, -A-3, -B-1, -B-2, -B-3 and -B-4". Pharmaceutical preparations containing the substances and methods of treating a host inflicted with a neoplastic growth with the preparation are described.
Patent JP-4532615-B2 (JP)
IPC: B29C48/18
Filed: 1998-12-24
Granted: 2010-08-25
Abstract: A plastic closure that comprises a cap (22) having a base (30) with a peripheral skirt (32) defining the cap interior and threads (34) on the skirt for securing the closure to a container. A liner (20a, 20b or 20c) is secured to the interior of the cap, preferably by being compression molded in situ on the base. The liner consists essentially of a multiplicity of alternating layers of a matrix polymer material such as EVA and a barrier material such as EVOH to resist transmission of gas, water vapor and/or flavorants through the liner. The matrix polymer material preferably is preblended with a compatibilizer material such as a maleic anhydride grafted polymer that ties the matrix polymer material to the barrier material. <IMAGE>
Patent JP-3226918-B2 (JP)
IPC: A61K45/06
Filed: 1991-10-01
Granted: 2001-11-12
Abstract: A composition of matter which comprises Tumor Necrosis Factor (TNF) and Interleukin-4 (IL-4) has been disclosed. This composition inhibited the growth of human breast cancer cells, human vulvar carcinoma cells and human histiocytic lymphoma cells a dose-dependent manner. The growth characteristics of human breast cancer cells were minimally affected when exposed to TNF or IL-4 alone. However, the combination of these two cytokines together inhibited the growth of these cells in a dose-dependent manner. Additionally, interferon-gamma (IFN-g) caused a further potentiation of the antiproliferative effects of the TNF and IL-4 composition.
Patent JP-2872254-B2 (JP)
IPC: H01S3/106
Filed: 1987-12-23
Granted: 1999-03-17
Abstract: Peptides and proteins related to an epitope comprising an outer membrane protein of Haemophilus influenzae. The peptides and proteins can be prepared by methods including novel and improved methods of purification from H. influenzae cultures, and by recombinant DNA and chemical synthetic techniques. Additionally, recombinant vectors containing nucleotide sequences encoding PBOMP-1 related peptides and proteins are also described. Recombinant vectors include plasmid DNA and viral DNA such as human viruses, animal viruses, insect viruses and bacteriophages that direct the expression of PBOMP-1 related peptides and proteins in appropriate host cells. The peptides, proteins and viruses both "live" and "inactivated" are used as immunogens in vaccine formulations to protect against H. influenzae infections. The peptides and proteins are also used as reagents in immunoassays as well as to prepare immunoglobulins for passage immunization. Use of the nucleotide sequences encoding the PBOMP related peptides and proteins in hybridization assays is also described.
Patent JP-2709388-B2 (JP)
IPC: G02B6/26
Filed: 1987-02-13
Granted: 1998-02-04
Abstract: A technique for reducing splice loss between similar or dissimilar optical fibres. Two fibres (10, 11) are joined by fusion splicing and the joint region is tapered until the cladding assumes a guiding function. This produces a mode transformer which converts the fundamental mode of one fibre to that of the other with little or negligible loss.